This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Calgary directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis
New England Journal of Medicine · 2020
Canadian chronic kidney disease clinics: a national survey of structure, function and models of care.
Canadian journal of kidney health and disease · 2014 · first author
Cohort profile: the chronic kidney disease prognosis consortium.
International journal of epidemiology · 2013
Latest funding
- $1,500,000
Prevention of Nephrotoxin-induced Acute Kidney Injury with Cilastatin (PONTIAC) Trial
CIHR · 2024 · Principal investigator
- $1,497,590
EQUIP Re-CKD: EQUity In Predicting Re-hospitalization among people with Chronic Kidney Disease
CIHR · 2024 · Co-investigator
- $20,000
Prevention of Nephrotoxin-induced Acute Kidney Injury with Cilastatin (PONTIAC) Trial
CIHR · 2023 · Co-investigator
5 publications.
Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis
Fujimoto S, Wald R, Levin A, Gregorini G, Clark WF, Pagnoux C, Specks U, Smyth L, Carette S, Pusey CD
Canadian chronic kidney disease clinics: a national survey of structure, function and models of care.
Levin A, Steven S, Selina A, Flora A, Sarah G, Braden M
Cohort profile: the chronic kidney disease prognosis consortium.
Matsushita K, Ballew SH, Astor BC, Jong PE, Gansevoort RT, Hemmelgarn BR, Levey AS, Levin A, Wen CP, Woodward M, Coresh J, Chronic Kidney Disease Prognosis Consortium
Knowledge translation for nephrologists: strategies for improving the identification of patients with proteinuria.
Hemmelgarn BR, Manns BJ, Straus S, Naugler C, Holroyd-Leduc J, Braun TC, Levin A, Klarenbach S, Lee PF, Hafez K, Schwartz D, Jindal K, Ervin K, Bello A, Turin TC, McBrien K, Elliott M, Tonelli M, Interdisciplinary Chronic Disease Collaboration ICDC
Citrate 4% versus heparin and the reduction of thrombosis study (CHARTS).
Macrae JM, Dojcinovic I, Djurdjev O, Jung B, Shalansky S, Levin A, Kiaii M
Prevention of Nephrotoxin-induced Acute Kidney Injury with Cilastatin (PONTIAC) Trial
Principal investigators: James, Matthew T; Levin, Adeera; Pannu, Neesh I
Keywords: Cardiovascular Disease; Kidney Disease; Nephrotoxicity; Randomized Controlled Trial
EQUIP Re-CKD: EQUity In Predicting Re-hospitalization among people with Chronic Kidney Disease
Principal investigators: Elliott, Meghan; Pannu, Neesh I; Donald, Maoliosa (Mo); Harrison, Tyrone; Ravani, Pietro
Keywords: Health Equity; Kidney Disease; Multiple Methods; Participatory Research; Re-Hospitalization; Risk Prediction
Prevention of Nephrotoxin-induced Acute Kidney Injury with Cilastatin (PONTIAC) Trial
Principal investigators: James, Matthew T; Muruve, Daniel A; Pannu, Neesh I
Keywords: Cardiovascular Disease; Clinical Trial; Kidney Disease; Nephrotoxicity
A Prognostic Tool To Inform Management of Acute Coronary Syndrome in People with Kidney Disease
Principal investigators: James, Matthew T
Keywords: Acute Coronary Syndrome; Cardiac Catheterization; Chronic Kidney Disease; Prognosis; Risk Prediction Models
Better Prediction and Decision Support Tools to Improve Care and Outcomes for Patients with Acute Kidney Injury (AKI)
Principal investigators: James, Matthew T
Keywords: Acute Kidney Injury; Clinical Decision Support; Clinical Informatics; Implementation Science; Outcomes Research; Risk Prediction
Canadian Innovative Methods involving Patients and Researchers in Outcome ImprovEments for Chronic Kidney Disease (Can-IMPROVE CKD): a strategic planning meeting
Principal investigators: Manns, Braden J; Levin, Adeera
Keywords: Chronic Kidney Disease; Clinicians; Patients; Research Priorities; Strategic Planning Meeting
Implementation and evaluation of a clinical pathway for chronic kidney disease in primary care
Principal investigators: Hemmelgarn, Brenda R; Braun, Ted C; Noseworthy, Thomas W; Manns, Braden J; Tonelli, Marcello
Keywords: Chronic Kidney Disease; Clinical Pathways; Knowledge Translation; Policy Decision-Making
The CAnadian KidNey KNowledge Translation and Generation NETwork (CANN-NET)
Principal investigators: Manns, Braden J; Levin, Adeera; Garg, Amit; Hemmelgarn, Brenda R; Klarenbach, Scott; Parfrey, Patrick S; Samuel, Susan M
Keywords: Clinical Practice Guidelines; Clinical Trials; Health Economics; Knowledge Translation; Nephrology; Network
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Medicine
- Nephrology
- Medicine/Nephrology
- Family Medicine
- Pediatrics
- Pathology and Laboratory Medicine
- Surgery
- Other
Co-authors at University of Calgary, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Adeera Levin
Pediatrics
2 shared papers, latest 2012
Adeera Levin
Nephrology
1 shared papers, latest 2020
Kerry McBrien
Community Health Sciences
1 shared papers, latest 2012
Jayna Holroyd-Leduc
Surgery
1 shared papers, latest 2012
Scott Klarenbach
Medicine
1 shared papers, latest 2012
Aminu Bello
Medicine
1 shared papers, latest 2012
Meghan Elliott
Medicine
1 shared papers, latest 2012
Sharon Straus
Family Medicine
1 shared papers, latest 2012
Kailash Jindal
Medicine
1 shared papers, latest 2012
Adeera Levin
Faculty
1 shared papers, latest 2020
Jayna Holroyd-Leduc
Family Medicine
1 shared papers, latest 2012
Aminu Bello
Faculty
1 shared papers, latest 2012
Michael Walsh
Medicine
1 shared papers, latest 2020
Nader Khalidi
Medicine
1 shared papers, latest 2020
Ron Wald
Medicine/Nephrology
1 shared papers, latest 2020
Marcello Tonelli
Medicine
1 shared papers, latest 2012
Adeera Levin
Medicine/Nephrology
1 shared papers, latest 2020
Ron Wald
Nephrology
1 shared papers, latest 2020
Michael Walsh
Faculty
1 shared papers, latest 2020
Christopher Naugler
Pathology and Laboratory Medicine
1 shared papers, latest 2012
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.